Miao proposed [105] in his letter that ZBP1, a marker of cuproptosis‐related genes and necrotic apoptosis‐related genes, could be used as a risk score for predicting the prognosis of low‐grade glioma patients. This evidence concerns the gene ZBP1 and central nervous system cancer.